trial · primary record
Allogenic Human Islet Cells
Type 1 Diabetes Mellitus
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2027-08-31 |
| Primary endpoint | Proportion of subjects who are insulin independent, hypoglycemia free, AND with hemoglobin A1c < or = 6.5% at 1 year post-transplant |
| Registry ID | NCT01909245 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:52.324Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01909245
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.